Analyst Ratings https://www.benzinga.com/views/taxonomy/term/67 en CIO Leadership: Hunter Muller Predicts that Tech Investments Will Remain Exceptionally Strong as Successful Organizations Are Built on Solid Foundations of Superior Technology https://www.benzinga.com/pressreleases/19/10/g14641145/cio-leadership-hunter-muller-predicts-that-tech-investments-will-remain-exceptionally-strong-as-su <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>WESTPORT, Conn., Oct. 22, 2019 (GLOBE NEWSWIRE) -- In order to compete in the 21<sup>st</sup> century, every large-scale global company must view itself as a technology company. Success is no longer about just delivering the best products and services, said Hunter Muller, President and CEO of HMG Strategy. It&#039;s about understanding precisely what customers want, then accelerating the digital experience by providing a platform of simplicity and connectivity.<br /></p> <p>"Companies that pull back on technology investments put their competitive position at risk," he said.</p> <p>Muller <a href="https://www.globenewswire.com/Tracker?data=UFBwGPDliSRIOVTzJo7aX1VJ6ZMsiCSOPRKaGfRmB0ZWwot3vOVg7S2V7huEad3l9Ikwl042P9WGMgVUGW6rjUuzx4b4gAEDn7rsZ-cJaeAoXbH3HycG3o2PQIjSL1kPDWUUA6aFX2W2YyRAjX3tLbwB3k8Lolr0MsTuW-XXnQoqRmNBtkwoofVF2_rp8N9WfnLpxCFOGBRnq29yA1JdL-LChVMxfn2weoHvf6MhXGNaD8as-F11de5lRdO2aV-p" rel="nofollow" target="_blank" rel="nofollow"><u>recently wrote</u></a> about an early October stock market spike. He followed up in a new <a href="https://www.globenewswire.com/Tracker?data=OUBTKGahVh70HRu9Axf4zMhXpRzKcmd-hnpLKwfn9oaFLjPSRgRlqRLcm50Vn_4m-z2MlgLCGmDqihkkFYp2eLlAU7wB7sLYTj4E7w_eZ81SJjRO6OQ0Di_dIC8OFa2CmKRLmMzeZ6VLQEB7a76uoCde3DDBuXCaf2Bq2SjH9VzBqnkDfKFJk9qucM_agKFXq67E_BoVpsso3PbGX-HzBsOfHpGV5aH3-xOROlABljahA2fk3FBsh5240IeWF4-hA6igTGmyctAKGbs0LxS5BUATRnfLJB5hHtHMMysLLII=" rel="nofollow" target="_blank" rel="nofollow"><u>article</u></a>, pointing out that although market analysts are taking a cautious approach to tech investments in the upcoming year, <a href="https://www.globenewswire.com/Tracker?data=Oz_CX5Fxg4KVJ-spodcPFJsx03q3sqp0yv6YsBf5QRj4v7sRjkhX6t0mhqNaKX59SzeS5Fr9dZQwSnQ5Or55it3kNALqIc75ydEgWoEVZnMzbdsm76g04raTe1VxDAlrIg5uWCw7H01NefCcuu5olwVw83tPw8R4uRmRuHWp6UcA7JjD-aHiPqyWPvBYcvFJ" rel="nofollow" target="_blank" rel="nofollow"><u>according to a Barron&#039;s article</u></a>, the strong performance in major markets lately is no fluke, and should continue going forward.</p> <p>"As technology leaders, we understand what&#039;s really driving the modern economy," Muller said. "We understand the incredible impact of technology on the broader culture."</p> <p>Talent, expertise and strategic planning are at the core of this business savvy, said Muller, ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14641145/cio-leadership-hunter-muller-predicts-that-tech-investments-will-remain-exceptionally-strong-as-su alt=CIO Leadership: Hunter Muller Predicts that Tech Investments Will Remain Exceptionally Strong as Successful Organizations Are Built on Solid Foundations of Superior Technology>Full story available on Benzinga.com</a></p> Analyst Ratings Press Releases Analyst Ratings Press Releases Benzinga Tue, 22 Oct 2019 22:07:05 +0000 Globe Newswire 14641145 at https://www.benzinga.com Analyst: Silicon Motion Technology's Near-Term Prospects Already Backed Into Estimates https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14636767/analyst-silicon-motion-technologys-near-term-prospects-already-backed-into-estimate <p>While <strong>Silicon Motion Technology Corp.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/simo#NASDAQ">SIMO</a>) has favorable near-term customer tailwinds and may generated meaningful earnings growth over the intermediate term, the estimates for the back half of 2019 already reflect its favorable momentum, according to Wedbush.</p> <h3>The Analyst</h3> <p>Wedbush&rsquo;s <a href="https://www.tipranks.com/analysts/matt-bryson">Matt Bryson</a> initiated coverage of Silicon Motion Technology with a Neutral rating and a price target of $39.</p> <h3>The Thesis</h3> <p>Although near-term momentum appears favorable for Silicon Motion Technology, there are potential macro concerns and future customer risk that could impact performance in 2021, Bryson ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14636767/analyst-silicon-motion-technologys-near-term-prospects-already-backed-into-estimate alt=Analyst: Silicon Motion Technology&#039;s Near-Term Prospects Already Backed Into Estimates>Full story available on Benzinga.com</a></p> Analyst Color Matt Bryson SIMO Wedbush Price Target Initiation Analyst Ratings Tech SIMO US82706C1080 Analyst Color Price Target Initiation Analyst Ratings Tech Benzinga Tue, 22 Oct 2019 21:02:26 +0000 Priya Nigam 14636767 at https://www.benzinga.com Wedbush Remains A Del Taco Bull Despite Disappointing Quarter https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14637207/wedbush-remains-a-del-taco-bull-despite-disappointing-quarter <p>Mexican-American quick service restaurant chain <strong>Del Taco Restaurants Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/taco#NASDAQ">TACO</a>) reported disappointing <a href="https://www.benzinga.com/pressreleases/19/10/b14630667/del-taco-restaurants-inc-reports-fiscal-third-quarter-2019-financial-results">third quarter results</a> Monday afternoon which could result in a &quot;realistic bar&quot; moving forward, according to Wedbush.</p> <h3>The Analyst</h3> <p>Wedbush analyst <a href="https://www.tipranks.com/analysts/nick-setyan">Nick Setyan</a> maintains an Outperform rating on Del Taco with a price target lowered from $13 to $11.</p> <h3>The Thesis</h3> <p>Del Taco&#39;s management offered some fourth quarter to date commentary which points to a sequential improvement in comp trends, Setyan wrote in a note. In addition, management&#39;s full-year 2019 same-store sales growth guidance of 1.0% (prior low-single-digit) still suggests a slight improvement on a two-year comp basis.</p> <p>Same-store sales ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14637207/wedbush-remains-a-del-taco-bull-despite-disappointing-quarter alt=Wedbush Remains A Del Taco Bull Despite Disappointing Quarter>Full story available on Benzinga.com</a></p> Analyst Color Earnings News Nick Setyan QSR TACO Wedbush Price Target Restaurants Analyst Ratings General TACO News Analyst Color Earnings Price Target Restaurants Analyst Ratings General Benzinga Tue, 22 Oct 2019 20:56:56 +0000 Jayson Derrick 14637207 at https://www.benzinga.com Analyst: Dim Outlook For Solar Sector In 2020 https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14639174/analyst-dim-outlook-for-solar-sector-in-2020 <p>As the sun goes away, so does the optimism for the <a href="https://www.benzinga.com/topic/solar">solar</a> sector. Even before the year is over, it appears&nbsp;that 2020 will be rough for some alternative energy companies.&nbsp;&nbsp;</p> <h3>What Happened</h3> <p>Longi Solar, a manufacturer of monocrystalline solar cells and modules, reported third-quarter&nbsp;results last week that did not meet expectations.</p> <p>The China-traded company traded lower, as preliminary earnings were 10% below the consensus estimate at the midpoint, according to GLJ Research.</p> <p>&quot;In short, based on our checks this morning in China, we believe weaker-than-expected module shipments are likely the reason for Longi&#39;s (large) 3Q19 earnings miss,&quot; GLJ Research&#39;s Gordon Johnson said ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14639174/analyst-dim-outlook-for-solar-sector-in-2020 alt=Analyst: Dim Outlook For Solar Sector In 2020>Full story available on Benzinga.com</a></p> Analyst Color CSIQ ENPH FSLR GLJ Research Gordon Johnson JKS News RUN SEDG Solar SPWR VSLR Analyst Ratings CSIQ CA1366351098 FSLR US3364331070 JKS US47759T1007 SPWR ENPH VSLR SEDG RUN News Analyst Color Analyst Ratings Benzinga Tue, 22 Oct 2019 20:38:38 +0000 Tyree Gorges 14639174 at https://www.benzinga.com 43 Percent of U.S. Commercial Trucks Now Powered by Newest-Generation Near-Zero Emissions Diesel Technology, Delivering Significant Emissions Reductions and Fuel Savings https://www.benzinga.com/pressreleases/19/10/g14639361/43-percent-of-u-s-commercial-trucks-now-powered-by-newest-generation-near-zero-emissions-diesel-te <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>WASHINGTON, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The newest, cleanest, near-zero-emissions diesel truck technologies now make up nearly half the U.S. fleet, jumping by 6.8 percent between Dec. 2017 and July 2019, according to new research from the <a href="https://www.globenewswire.com/Tracker?data=kJ7jvVn4iaWdw--ScoxOxyeqpnhsGFTm2dGdx-oAIHHvT7iJ2kTUfQH-ao7wuZ4eGSHN3r8XM6fzoP1ZimEng8BMeDKJ-6jOQBtH3sggRzA=" rel="nofollow" target="_blank" rel="nofollow">Diesel Technology Forum</a>. Since these cleaner diesel trucks were introduced in 2007, significant clean air and fuel efficiency benefits have been delivered to American consumers, with even greater environmental gains projected through 2030.</p> <p>"As more of America&#039;s commercial trucks rely on the newest, cleanest diesel technologies, greater air quality and fuel savings benefits are being realized by communities across the country," said Allen Schaeffer, executive director of the Diesel Technology Forum. "Since 2007, the newest-generation diesel trucks on U.S. roads have eliminated 126 million tonnes of carbon dioxide (CO2), 18 million tonnes of nitrogen oxides (NOx) and 1 million tonnes of particulate matter (PM), and saved 12.4 billion gallons of diesel and 296 million barrels of crude oil. Put into context, the emissions and fuel savings attributable to new-generation diesel engines in commercial trucks is astounding: they equate to making 26 million cars all-electric, eliminating the PM emissions from all U.S. cars for 33 years, achieving carbon sequestration in a forest roughly the size of Texas, or creating a 27,000-turbine wind farm on land four times the size of Washington, D.C. – all benefits achieved thanks to the increasing adoption of the newest generation of advanced diesel engines."</p> <p>Beginning in 2011, all new heavy-duty trucks have been equipped with <a href="https://www.globenewswire.com/Tracker?data=y-nWWT82tblcgTNocB5M6-i1WM5fMBrN-r6ViDKtMtG6YsOmy-yo2ke972lQ5s3dVJ423UVzRcXC16rsrjrKgiK_NKUod65hMTjdpnpmDbNANOgqP_bDyYwentQi1nfaWnveagbFnr3n-XiEOZPDh3l5mv1ZTpU7oQ5KnBvUiHFdB1k1N97Yg43XoYlVhx-_qd-MyDiTn45BoXnEgYm6UA==" rel="nofollow" target="_blank" rel="nofollow">selective catalytic reduction (SCR) and ...</a></p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14639361/43-percent-of-u-s-commercial-trucks-now-powered-by-newest-generation-near-zero-emissions-diesel-te alt=43 Percent of U.S. Commercial Trucks Now Powered by Newest-Generation Near-Zero Emissions Diesel Technology, Delivering Significant Emissions Reductions and Fuel Savings>Full story available on Benzinga.com</a></p> 43 6 Retail Sales Economics Analyst Ratings Press Releases General 6 43 Retail Sales Economics Analyst Ratings Press Releases General Benzinga Tue, 22 Oct 2019 19:05:05 +0000 Globe Newswire 14639361 at https://www.benzinga.com Buckingham Bullish On Owens Corning Ahead Of Q3 Earnings Print https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14636839/buckingham-bullish-on-owens-corning-ahead-of-q3-earnings-print <p>Roofing company <strong>Owens Corning</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oc#NYSE">OC</a>) is expected to discuss on its third-quarter conference call signs of an improving residential end market, according to Buckingham.</p> <h3>The Analyst</h3> <p>Buckingham Research Group analyst <a href="https://www.tipranks.com/analysts/megan-mcgrath">Megan McGrath</a> upgraded Owens Corning from Neutral to Buy with a price target lifted from $59 to $79.</p> <h3>The Thesis</h3> <p>McGrath said the case for turning bullish on Owens Corning&#39;s stock isn&#39;t based on exceptions for a strong third quarter, but rather due to longer-term trends. Specifically, the company&#39;s insulation business should show signs of momentum in Wednesday&#39;s earnings print but will improve in 2020 from a lack of curtailment expenses, better U.S. volumes and potential ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14636839/buckingham-bullish-on-owens-corning-ahead-of-q3-earnings-print alt=Buckingham Bullish On Owens Corning Ahead Of Q3 Earnings Print>Full story available on Benzinga.com</a></p> Analyst Color Buckingham construction Megan McGrath OC Roofing Upgrades Price Target Previews Analyst Ratings Trading Ideas OC US6907421019 Analyst Color Upgrades Price Target Previews Analyst Ratings Trading Ideas Benzinga Tue, 22 Oct 2019 18:09:07 +0000 Jayson Derrick 14636839 at https://www.benzinga.com Has The 737 Max Put Boeing's Dividend At Risk? https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14638600/has-the-737-max-put-boeings-dividend-at-risk <p><strong>Boeing Co </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ba#NYSE">BA</a>) shares are down 11% in the past six months as the problems that grounded the 737 Max have proven more difficult to solve than many investors anticipated. Fortunately for Boeing bulls, one analyst said at least patient investors will likely continue to get paid to wait.</p> <h3>The Analyst</h3> <p>Bank of America analyst <a href="https://www.tipranks.com/analysts/ronald-epstein">Ronald Epstein</a> reiterated his Neutral rating and $370 price target for Boeing.</p> <h3>The Thesis</h3> <p>Boeing shares took a big hit last Friday after the FAA reported <a href="https://www.benzinga.com/government/19/10/14622672/faa-concerned-about-boeing-text-messages-that-may-indicate-company-misled-agency-on-737-max">&ldquo;concerning&rdquo; instant messages </a>between two Boeing employees that took place during the original certification of the 737 Max back in 2016. In response, Epstein lowered his price target for Boeing from $400 to $370 on Monday, noting that corporate governance concerns could ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14638600/has-the-737-max-put-boeings-dividend-at-risk alt=Has The 737 Max Put Boeing&#039;s Dividend At Risk?>Full story available on Benzinga.com</a></p> 737 MAX Analyst Color BA Bank of America Ronald Epstein Dividends Price Target Reiteration Top Stories Analyst Ratings Trading Ideas BA US0970231058 Analyst Color Dividends Price Target Reiteration Top Stories Analyst Ratings Trading Ideas Benzinga Tue, 22 Oct 2019 17:40:54 +0000 Wayne Duggan 14638600 at https://www.benzinga.com Animal Vaccines Market Analysis Report, 2018-2025 - World Market to be Valued at $12.84 Billion by 2025 https://www.benzinga.com/pressreleases/19/10/g14638005/animal-vaccines-market-analysis-report-2018-2025-world-market-to-be-valued-at-12-84-billion-by-202 <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Dublin, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/4828930/animal-vaccines-market-by-product-type-and-animal?utm_source=GNOM&amp;utm_medium=PressRelease&amp;utm_code=cd33r8&amp;utm_campaign=1311013+-+Animal+Vaccines+Market+Analysis+Report%2c+2018-2025+-+World+Market+to+be+Valued+at+%2412.84+Billion+by+2025&amp;utm_exec=joca220prd" rel="nofollow" target="_blank" rel="nofollow">&#34;Animal Vaccines Market by Product Type and Animal Type: Global Opportunity Analysis and Industry Forecast, 2018 - 2025&#34;</a> report has been added to <strong>ResearchAndMarkets.com&#39;s</strong> offering.<br /> <br /> According to this report, the global animal vaccines market accounted for $8,059 in 2017, and is estimated to reach $12,845 million by 2025, registering a CAGR of 5.9% from 2018 to 2025.<br /><br />Increase in adoption of companion animals in the developing countries is the major factor that drives the growth of this market. The market has witnessed moderate growth in recent years due to emerging diseases that affect livestock. The outbreak of epidemics results in severe mass wipeouts of animals, and is a growing concern for the industries dependent on products obtained through farm animals. Moreover, zoonotic diseases that affect animals pose a threat to the public health, hence avoiding transmission of such diseases via vaccination is a significant factor in disease management.<br /><br />Based on animal type, the animal vaccines market is classified into companion animals, cattle, pigs, poultry, and sheep. The companion ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14638005/animal-vaccines-market-analysis-report-2018-2025-world-market-to-be-valued-at-12-84-billion-by-202 alt=Animal Vaccines Market Analysis Report, 2018-2025 - World Market to be Valued at $12.84 Billion by 2025>Full story available on Benzinga.com</a></p> Analyst Ratings Press Releases Analyst Ratings Press Releases Benzinga Tue, 22 Oct 2019 16:14:48 +0000 Globe Newswire 14638005 at https://www.benzinga.com Orthobiologics | World Markets to 2025: A $6.87 Billion Industry Outlook https://www.benzinga.com/pressreleases/19/10/g14637939/orthobiologics-world-markets-to-2025-a-6-87-billion-industry-outlook <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Dublin, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/4828924/orthobiologics-market-by-product-application?utm_source=GNOM&amp;utm_medium=PressRelease&amp;utm_code=wpm9bp&amp;utm_campaign=1310998+-+Orthobiologics+%7c+World+Markets+to+2025%3a+A+%246.87+Billion+Industry+Outlook&amp;utm_exec=joca220prd" rel="nofollow" target="_blank" rel="nofollow">&#34;Orthobiologics Market by Product, Application, Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025&#34;</a> report has been added to <strong>ResearchAndMarkets.com&#39;s</strong> offering.<br /> <br /> According to this report, the market was valued at $4,870 million in 2017, and is projected to reach $6,870 million by 2025, growing at a CAGR of 4.3% from 2018 to 2025.<br /><br />The key factors that drive the growth of the global orthobiologics market are increase demand for advanced treatment and rise in prevalence of osteoarthritis, degenerative arthritis, spinal injuries, and soft tissue injuries majorly drive the growth of the market. Further, rise in obesity rate, growth in awareness among the patients, and increase in geriatric population supports the market growth. However, high cost of procedures and stringent regulatory approval process restrict the growth of this market. Advancements in implant technologies and growth in demand for biological solutions create opportunities for market growth.<br /><br />The global orthobiologics market is segmented based on product, application, type, end user, and region. Based on product, the market is classified into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others. Viscosupplementation products is the largest and the fastest growing segment. This is due to its application for treatment of knee pain associated with osteoarthritis. Increase in geriatric population, rise in prevalence of osteoarthritis, and growth ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14637939/orthobiologics-world-markets-to-2025-a-6-87-billion-industry-outlook alt=Orthobiologics | World Markets to 2025: A $6.87 Billion Industry Outlook>Full story available on Benzinga.com</a></p> Analyst Ratings Press Releases Analyst Ratings Press Releases Benzinga Tue, 22 Oct 2019 16:10:39 +0000 Globe Newswire 14637939 at https://www.benzinga.com 2019 Report on Cell Harvesting: Market Projected to Grow by $157.2M During 2019-2025 https://www.benzinga.com/pressreleases/19/10/g14637896/2019-report-on-cell-harvesting-market-projected-to-grow-by-157-2m-during-2019-2025 <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Dublin, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/4804663/cell-harvesting-market-analysis-trends-and?utm_source=GNDIY&amp;utm_medium=PressRelease&amp;utm_code=6q3xr4&amp;utm_campaign=1311034+-+2019+Report+on+Cell+Harvesting%3a+Market+Projected+to+Grow+by+%24157.2M+During+2019-2025&amp;utm_exec=joca220prd" rel="nofollow" target="_blank" rel="nofollow">&#34;Cell Harvesting - Market Analysis, Trends, and Forecasts&#34;</a> report has been added to <strong>ResearchAndMarkets.com&#39;s</strong> offering.<br /> <br /> The Cell Harvesting market worldwide is projected to grow by US$157.2 Million, driven by a compounded growth of 8.4%.<br /><br />Manual Cell Harvesters, one of the segments analyzed and sized in this study, displays the potential to grow at over 9.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$269.7 Million by the year 2025, Manual Cell Harvesters will bring in healthy gains adding significant momentum to global growth.<br /><br />Representing the developed world, the United States will maintain a 9.6% growth ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14637896/2019-report-on-cell-harvesting-market-projected-to-grow-by-157-2m-during-2019-2025 alt=2019 Report on Cell Harvesting: Market Projected to Grow by $157.2M During 2019-2025>Full story available on Benzinga.com</a></p> Analyst Ratings Press Releases Analyst Ratings Press Releases Benzinga Tue, 22 Oct 2019 16:05:03 +0000 Globe Newswire 14637896 at https://www.benzinga.com Oncology/Cancer Drugs Market Set to Exceed $176 Billion by 2025 - Key Industry Insights & Growth Opportunities https://www.benzinga.com/pressreleases/19/10/g14637792/oncologycancer-drugs-market-set-to-exceed-176-billion-by-2025-key-industry-insights-growth-opportu <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Dublin, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/4828906/oncologycancer-drugs-market-by-drug-class-type?utm_source=GNOM&amp;utm_medium=PressRelease&amp;utm_code=bgnzsq&amp;utm_campaign=1311028+-+Oncology%2fCancer+Drugs+Market+Set+to+Exceed+%24176+Billion+by+2025+-+Key+Industry+Insights+%26+Growth+Opportunities&amp;utm_exec=joca220prd" rel="nofollow" target="_blank" rel="nofollow">&#34;Oncology/Cancer Drugs Market by Drug Class Type and Indication: Global Opportunity Analysis and Industry Forecast, 2018 - 2025&#34;</a> report has been added to <strong>ResearchAndMarkets.com&#39;s</strong> offering.<br /> <br /> According to this report, the market was valued at $97,401 million in 2017, and is projected to reach $176,509 million by 2025, growing at a CAGR of 7.6% from 2018 to 2025.<br /><br />The key drivers of the global oncology/cancer drugs market are surge in geriatric population and rise in collaborations &amp; partnerships to facilitate drug development. In addition, surge in prevalence of cancer and increase in healthcare expenditure have significantly contributed toward the growth of this market. Increase in number of pipeline drugs along with high potential of emerging economies are further expected to provide lucrative opportunities for market expansion. However, adverse effects related to cancer drugs impede the market growth.<br /><br />The global oncology/cancer drugs market ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14637792/oncologycancer-drugs-market-set-to-exceed-176-billion-by-2025-key-industry-insights-growth-opportu alt=Oncology/Cancer Drugs Market Set to Exceed $176 Billion by 2025 - Key Industry Insights &amp; Growth Opportunities>Full story available on Benzinga.com</a></p> Analyst Ratings Press Releases Analyst Ratings Press Releases Benzinga Tue, 22 Oct 2019 16:03:57 +0000 Globe Newswire 14637792 at https://www.benzinga.com Varicose Vein Treatment, Market Outlook to 2025 - Endovenous Ablation Devices Segment Projected to Experience a Rapid Growth Rate https://www.benzinga.com/pressreleases/19/10/g14637701/varicose-vein-treatment-market-outlook-to-2025-endovenous-ablation-devices-segment-projected-to-ex <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Dublin, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/4828879/varicose-vein-treatment-market-by-procedure?utm_source=GNOM&amp;utm_medium=PressRelease&amp;utm_code=fbkwtk&amp;utm_campaign=1311002+-+Varicose+Vein+Treatment%2c+Market+Outlook+to+2025+-+Endovenous+Ablation+Devices+Segment+Projected+to+Experience+a+Rapid+Growth+Rate&amp;utm_exec=joca220prd" rel="nofollow" target="_blank" rel="nofollow">&#34;Varicose Vein Treatment Market by Procedure, Product and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025&#34;</a> report has been added to <strong>ResearchAndMarkets.com&#39;s</strong> offering.<br /> <br /> According to this report, the global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, growing at a CAGR of 5.7% from 2018 to 2025.<br /><br />Growth in geriatric population and increase in cases of asthma drive the growth of the global varicose vein treatment market. Moreover, some of the factors such as increase in healthcare expenditure and better clinical outcomes fuel the market growth. However, product recall and lack of skilled healthcare professionals are expected to hinder the growth of the global market.<br /><br />Based on procedure, the global varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Currently, the injection sclerotherapy segment is leading the market and is estimated to grow at the highest rate. While, endovenous ablation devices are estimated to ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14637701/varicose-vein-treatment-market-outlook-to-2025-endovenous-ablation-devices-segment-projected-to-ex alt=Varicose Vein Treatment, Market Outlook to 2025 - Endovenous Ablation Devices Segment Projected to Experience a Rapid Growth Rate>Full story available on Benzinga.com</a></p> Analyst Ratings Press Releases Analyst Ratings Press Releases Benzinga Tue, 22 Oct 2019 15:57:51 +0000 Globe Newswire 14637701 at https://www.benzinga.com Global Autotransfusion Devices & Consumables Markets to 2026 https://www.benzinga.com/pressreleases/19/10/g14637646/global-autotransfusion-devices-consumables-markets-to-2026 <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Dublin, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/4828566/autotransfusion-devices-and-consumables-market-by?utm_source=GNOM&amp;utm_medium=PressRelease&amp;utm_code=zkcgvp&amp;utm_campaign=1311024+-+Global+Autotransfusion+Devices+%26+Consumables+Markets+to+2026&amp;utm_exec=joca220prd" rel="nofollow" target="_blank" rel="nofollow">&#34;Autotransfusion Devices and Consumables Market by Product Type and End Use: Global Opportunity Analysis and Industry Forecast, 2019-2026&#34;</a> report has been added to <strong>ResearchAndMarkets.com&#39;s</strong> offering.<br /><br /> According to this report, the global autotransfusion devices and consumables market size was valued to be at $864 million in 2018 and is expected to increase during the forecast period to be at $1,380 million by 2026, registering a CAGR of 6.1% from 2019 to 2026. The devices segment accounted for more than two-thirds of the total market share in 2018.<br /><br />The global autotransfusion devices and consumables market share has witnessed significant growth in the past few years. The growth in awareness regarding the lesser risk of transfusion transmitted infection. The rise in preference of autotransfusion techniques over allogeneic methods for blood transfusion amongst the healthcare professionals and patient population due to its higher efficiency and less risk of contamination contribute toward the market growth.<br /><br />In addition, government of developing countries such as India and China are promoting the use of autotransfusion techniques considering its lower morbidity and mortality rate due to infection, which is further expected to ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14637646/global-autotransfusion-devices-consumables-markets-to-2026 alt=Global Autotransfusion Devices &amp; Consumables Markets to 2026>Full story available on Benzinga.com</a></p> Analyst Ratings Press Releases Analyst Ratings Press Releases Benzinga Tue, 22 Oct 2019 15:50:40 +0000 Globe Newswire 14637646 at https://www.benzinga.com Fetal Bovine Serum Market Set to Exceed $1 Billion by 2025 - Biopharmaceuticals Application Segment Anticipated to Grow at the Highest CAGR https://www.benzinga.com/pressreleases/19/10/g14637604/fetal-bovine-serum-market-set-to-exceed-1-billion-by-2025-biopharmaceuticals-application-segment-a <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Dublin, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/4828600/fetal-bovine-serum-market-by-application-and-end?utm_source=GNOM&amp;utm_medium=PressRelease&amp;utm_code=5f63jd&amp;utm_campaign=1310994+-+Fetal+Bovine+Serum+Market+Set+to+Exceed+%241+Billion+by+2025+-+Biopharmaceuticals+Application+Segment+Anticipated+to+Grow+at+the+Highest+CAGR&amp;utm_exec=joca220prd" rel="nofollow" target="_blank" rel="nofollow">&#34;Fetal Bovine Serum Market by Application and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025&#34;</a> report has been added to <strong>ResearchAndMarkets.com&#39;s</strong> offering.<br /> <br /> According to this report, the global fetal bovine serum market was valued at $695 million in 2017, and is projected to reach $ 1,037 million by 2025, growing at a CAGR of 5.1 % from 2018 to 2025. North America was the highest revenue contributor in 2017 and is anticipated to maintain the same trend throughout the forecast period.<br /><br />The growth of fetal bovine serum market size is primarily driven by the growing demand for biopharmaceuticals, rising biotech R&amp;D activities in developing economies and increase in the support from government for research activities across the globe.<br /><br />However, significant increase in its price within recent years is anticipated to hamper the fetal bovine serum market growth. Conversely, untapped potential of emerging markets are anticipated to provide lucrative opportunities in the near future to the key players operating in the fetal bovine serum market.<br /><br />Based on fetal bovine serum market trends by application, the cell culture segment accounted for the majority share of the global market in 2017. This is attributed to the fact that fetal bovine serum finds its application in performing various animal cell cultures. It is most widely used supplement for cell cultures.<br /><br />Depending on end user, the biotechnology &amp; pharmaceutical company segment generated the maximum revenue of in 2017, and is anticipated to exhibit prominent growth, due to significant rise in R&amp;D for the development of drugs, human &amp; animal vaccines and others.<br /><br ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14637604/fetal-bovine-serum-market-set-to-exceed-1-billion-by-2025-biopharmaceuticals-application-segment-a alt=Fetal Bovine Serum Market Set to Exceed $1 Billion by 2025 - Biopharmaceuticals Application Segment Anticipated to Grow at the Highest CAGR>Full story available on Benzinga.com</a></p> Analyst Ratings Press Releases Analyst Ratings Press Releases Benzinga Tue, 22 Oct 2019 15:45:06 +0000 Globe Newswire 14637604 at https://www.benzinga.com Insights Into the World Market of Food Enzymes, 2019 to 2026 | by Type, Application & Source https://www.benzinga.com/pressreleases/19/10/g14637596/insights-into-the-world-market-of-food-enzymes-2019-to-2026-by-type-application-source <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Dublin, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/4828579/food-enzymes-market-by-type-application-and?utm_source=GNDIY&amp;utm_medium=PressRelease&amp;utm_code=23tgmr&amp;utm_campaign=1311009+-+Insights+Into+the+World+Market+of+Food+Enzymes%2c+2019+to+2026+%7c+by+Type%2c+Application+%26+Source&amp;utm_exec=joca220prd" rel="nofollow" target="_blank" rel="nofollow">&#34;Food Enzymes Market by Type, Application, and Source: Global Opportunity Analysis and Industry Forecast, 2019-2026&#34;</a> report has been added to <strong>ResearchAndMarkets.com&#39;s</strong> offering.<br /> <br /> According to this report, the global food enzymes market size was $1,944.8 million in 2018, and is projected to reach $3,056.9 million by 2026, registering a CAGR of 5.6% from 2019 to 2026. In terms of volume, North America occupied more than one-third of the global market share for 2018 and is expected to maintain its dominance during the forecast period.<br /><br />Developments in protein and genetic engineering have resulted in the improvement of economy, specificity, stability, and overall application potential of food enzymes. Food enzymes find application on plethora of platforms such as starch modification, sweetener production, sugar processing, baking, flour supplementation, dough conditioning, cheesemaking, brewing, flavor enhancement, meat tenderizing, and juice processing.<br /><br />The application of enzymes in food processing is governed by various national and international agencies across the world. For general purposes, the Food Chemicals Codex (FCC) and FAO/WHO Joint Expert Committee on Food Additives (JECFA) have ...</p><p><a href=https://www.benzinga.com/pressreleases/19/10/g14637596/insights-into-the-world-market-of-food-enzymes-2019-to-2026-by-type-application-source alt=Insights Into the World Market of Food Enzymes, 2019 to 2026 | by Type, Application &amp; Source>Full story available on Benzinga.com</a></p> Analyst Ratings Press Releases Analyst Ratings Press Releases Benzinga Tue, 22 Oct 2019 15:44:52 +0000 Globe Newswire 14637596 at https://www.benzinga.com